NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free CLOV Stock Alerts $0.67 +0.02 (+3.08%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.64▼$0.6850-Day Range$0.62▼$0.9952-Week Range$0.61▼$1.63Volume3.89 million shsAverage Volume8.77 million shsMarket Capitalization$331.85 millionP/E RatioN/ADividend YieldN/APrice Target$1.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Clover Health Investments alerts: Email Address Clover Health Investments MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside123.9% Upside$1.50 Price TargetShort InterestBearish9.72% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 5 Articles This WeekInsider TradingAcquiring Shares$100,010 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.20) to ($0.16) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.01 out of 5 starsMedical Sector658th out of 907 stocksHospital & Medical Service Plans Industry9th out of 11 stocks 3.0 Analyst's Opinion Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageClover Health Investments has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.72% of the outstanding shares of Clover Health Investments have been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in Clover Health Investments has recently increased by 9.50%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLOV. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 5 news articles for Clover Health Investments this week, compared to 2 articles on an average week.Search InterestOnly 24 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -23% compared to the previous 30 days.MarketBeat FollowsOnly 12 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,010.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders21.82% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.77% of the stock of Clover Health Investments is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Clover Health Investments are expected to grow in the coming year, from ($0.20) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -1.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -1.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Clover Health Investments Stock (NASDAQ:CLOV)Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.Read More CLOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLOV Stock News HeadlinesApril 24, 2024 | finanznachrichten.deClover Health Investments, Corp.: Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerApril 23, 2024 | globenewswire.comClover Health to Report First Quarter 2024 Financial Results on May 7, 2024April 25, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 22, 2024 | marketwatch.comClover Health Names Peter Kuipers as New CFOApril 22, 2024 | globenewswire.comClover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial OfficerApril 9, 2024 | msn.comThe 26 Best Gym Bags For Your Workout EssentialsApril 6, 2024 | uk.investing.comClover Health settles shareholder lawsuits, enhances governanceApril 4, 2024 | globenewswire.comClover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative ActionsApril 25, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 4, 2024 | msn.comJMP starts HealthEquity at market outperform, cites revenue growthMarch 21, 2024 | markets.businessinsider.comCautious Optimism on Clover Health’s Performance with Concerns on Long-Term ProfitabilityMarch 20, 2024 | finance.yahoo.comInsider Spends US$110k Buying More Shares In Clover Health InvestmentsMarch 20, 2024 | investorplace.com3 Under-the-Radar Stocks to Transform $10K into $100K by 2028March 19, 2024 | globenewswire.comClover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental IllnessMarch 18, 2024 | finance.yahoo.comDowngrade: Here's How Analysts See Clover Health Investments, Corp. (NASDAQ:CLOV) Performing In The Near TermMarch 15, 2024 | finance.yahoo.comCLOV Mar 2024 2.000 callMarch 15, 2024 | benzinga.comPeering Into Clover Health Investments's Recent Short InterestMarch 15, 2024 | ca.finance.yahoo.comCLOV Mar 2024 2.000 putMarch 14, 2024 | seekingalpha.comClover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | finance.yahoo.comClover Health Investments Full Year 2023 Earnings: Beats ExpectationsMarch 13, 2024 | finance.yahoo.comClover Health Investments, Corp. (NASDAQ:CLOV) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | uk.style.yahoo.com27 show home tricks and how to spot themMarch 13, 2024 | markets.businessinsider.comClover Health Investments: Hold Rating with High Risk Amidst Progress Towards StabilityMarch 13, 2024 | finance.yahoo.comQ4 2023 Clover Health Investments Corp Earnings CallMarch 12, 2024 | globenewswire.comClover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 GuidanceMarch 11, 2024 | msn.comClover Health Q4 2023 Earnings PreviewMarch 11, 2024 | benzinga.comClover Health Investments's Earnings OutlookSee More Headlines Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/12/2024Today4/25/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Hospital & medical service plans Sub-IndustryN/A Current SymbolNASDAQ:CLOV CUSIPN/A CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees552Year FoundedN/APrice Target and Rating Average Stock Price Target$1.50 High Stock Price Target$1.50 Low Stock Price Target$1.50 Potential Upside/Downside+126.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-213,360,000.00 Net Margins-10.49% Pretax Margin-10.49% Return on Equity-62.58% Return on Assets-18.19% Debt Debt-to-Equity RatioN/A Current Ratio1.64 Quick Ratio1.64 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book1.12Miscellaneous Outstanding Shares495,290,000Free Float387,219,000Market Cap$328.43 million OptionableOptionable Beta1.84 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Vivek Garipalli (Age 45)Co-Founder & Executive Chairman Mr. Andrew Toy (Age 45)Co-Founder, CEO & Director Comp: $1.01MMr. Brady Priest J.D. (Age 47)Chief Executive Officer of Home Care Comp: $587.36kMr. Terrence Ronan (Age 64)Interim CFO, Principal Financial Officer & Principal Accounting Officer Mr. Conrad Wai (Age 43)Chief Technology Officer Mr. Derrick L. NuemanHead of Investor Relations & Corporate strategyMs. Wendy RicheyChief Compliance OfficerMs. Karen SoaresGeneral Counsel, Senior VP & Corporate SecretaryMs. Rachel FishChief People OfficerMs. Jamie L. Reynoso (Age 54)Chief Executive Officer of Medicare Advantage Comp: $461.74kMore ExecutivesKey CompetitorsSkillzNYSE:SKLZBright Health GroupNYSE:BHGDragoneer Growth OpportunitiesNYSE:DGNRAlignment HealthcareNASDAQ:ALHCViemed HealthcareNASDAQ:VMDView All CompetitorsInsiders & InstitutionsSimplex Trading LLCBought 179,800 shares on 4/25/2024Ownership: 0.000%Allspring Global Investments Holdings LLCBought 46,912 shares on 4/18/2024Ownership: 0.016%SignalPoint Asset Management LLCBought 40,000 shares on 4/11/2024Ownership: 0.028%Anna U LoengardBought 137,000 shares on 3/14/2024Total: $100,010.00 ($0.73/share)Jump Financial LLCBought 131,200 shares on 2/7/2024Ownership: 0.027%View All Insider TransactionsView All Institutional Transactions CLOV Stock Analysis - Frequently Asked Questions Should I buy or sell Clover Health Investments stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks. What is Clover Health Investments' stock price target for 2024? 1 Wall Street analysts have issued 1 year target prices for Clover Health Investments' stock. Their CLOV share price targets range from $1.50 to $1.50. On average, they expect the company's stock price to reach $1.50 in the next year. This suggests a possible upside of 123.9% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts. How have CLOV shares performed in 2024? Clover Health Investments' stock was trading at $0.9521 on January 1st, 2024. Since then, CLOV stock has decreased by 29.6% and is now trading at $0.67. View the best growth stocks for 2024 here. Are investors shorting Clover Health Investments? Clover Health Investments saw a increase in short interest in April. As of April 15th, there was short interest totaling 48,160,000 shares, an increase of 9.5% from the March 31st total of 43,980,000 shares. Based on an average trading volume of 9,190,000 shares, the days-to-cover ratio is currently 5.2 days. View Clover Health Investments' Short Interest. When is Clover Health Investments' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our CLOV earnings forecast. How can I listen to Clover Health Investments' earnings call? Clover Health Investments will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings results on Tuesday, March, 12th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.06. The business had revenue of $510.25 million for the quarter, compared to analyst estimates of $491.20 million. Clover Health Investments had a negative net margin of 10.49% and a negative trailing twelve-month return on equity of 62.58%. Who are Clover Health Investments' major shareholders? Clover Health Investments' stock is owned by a number of institutional and retail investors. Top institutional investors include Simplex Trading LLC (0.00%), SignalPoint Asset Management LLC (0.03%) and Allspring Global Investments Holdings LLC (0.02%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CLOV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
